BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 19538036)

  • 1. Targeted drug delivery for treatment and imaging of glioblastoma multiforme.
    Stukel JM; Caplan MR
    Expert Opin Drug Deliv; 2009 Jul; 6(7):705-18. PubMed ID: 19538036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convection-enhanced delivery to achieve widespread distribution of viral vectors: Predicting clinical implementation.
    Debinski W; Tatter SB
    Curr Opin Mol Ther; 2010 Dec; 12(6):647-53. PubMed ID: 21154156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents.
    Reardon DA; Wen PY
    Oncologist; 2006 Feb; 11(2):152-64. PubMed ID: 16476836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convection-enhanced delivery: targeted toxin treatment of malignant glioma.
    Hall WA; Sherr GT
    Neurosurg Focus; 2006 Apr; 20(4):E10. PubMed ID: 16709015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of nanoparticles for drug delivery in glioblastoma multiforme.
    Jain KK
    Expert Rev Neurother; 2007 Apr; 7(4):363-72. PubMed ID: 17425491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy delivery issues in central nervous system malignancy: a reality check.
    Muldoon LL; Soussain C; Jahnke K; Johanson C; Siegal T; Smith QR; Hall WA; Hynynen K; Senter PD; Peereboom DM; Neuwelt EA
    J Clin Oncol; 2007 Jun; 25(16):2295-305. PubMed ID: 17538176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug delivery strategies for the treatment of malignant gliomas.
    Allhenn D; Boushehri MA; Lamprecht A
    Int J Pharm; 2012 Oct; 436(1-2):299-310. PubMed ID: 22721856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive outlook on intracerebral therapy of malignant gliomas.
    Buonerba C; Di Lorenzo G; Marinelli A; Federico P; Palmieri G; Imbimbo M; Conti P; Peluso G; De Placido S; Sampson JH
    Crit Rev Oncol Hematol; 2011 Oct; 80(1):54-68. PubMed ID: 20888252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive pressure infusion of therapeutic agents into brain tissues: mathematical and experimental simulations.
    Gillies GT; Smith JH; Humphrey JA; Broaddus WC
    Technol Health Care; 2005; 13(4):235-43. PubMed ID: 16055972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
    Karim R; Palazzo C; Evrard B; Piel G
    J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glioblastoma treatment in 2010].
    Djedid R; Tomasi O; Haidara A; Rynkowski M; Lefranc F
    Rev Med Brux; 2009; 30(5):496-505. PubMed ID: 19998795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium.
    Doolittle ND; Abrey LE; Ferrari N; Hall WA; Laws ER; McLendon RE; Muldoon LL; Peereboom D; Peterson DR; Reynolds CP; Senter P; Neuwelt EA
    Clin Cancer Res; 2002 Jun; 8(6):1702-9. PubMed ID: 12060607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convection-enhanced delivery for glioblastoma: targeted delivery of antitumor therapeutics.
    Ung TH; Malone H; Canoll P; Bruce JN
    CNS Oncol; 2015; 4(4):225-34. PubMed ID: 26103989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal assessment of regional directed delivery in a rodent malignant glioma model.
    Kondo A; Goldman S; Lulla RR; Mania-Farnell B; Vanin EF; Sredni ST; Rajaram V; Soares MB; Tomita T
    J Neurosurg Pediatr; 2009 Dec; 4(6):592-8. PubMed ID: 19951051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convection-enhanced drug delivery for glioblastoma: a review.
    D'Amico RS; Aghi MK; Vogelbaum MA; Bruce JN
    J Neurooncol; 2021 Feb; 151(3):415-427. PubMed ID: 33611708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain.
    Saito R; Krauze MT; Bringas JR; Noble C; McKnight TR; Jackson P; Wendland MF; Mamot C; Drummond DC; Kirpotin DB; Hong K; Berger MS; Park JW; Bankiewicz KS
    Exp Neurol; 2005 Dec; 196(2):381-9. PubMed ID: 16197944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates.
    Simpson L; Galanis E
    Expert Rev Anticancer Ther; 2006 Nov; 6(11):1593-607. PubMed ID: 17134364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: implications for local drug delivery.
    Saito R; Krauze MT; Noble CO; Tamas M; Drummond DC; Kirpotin DB; Berger MS; Park JW; Bankiewicz KS
    J Neurosci Methods; 2006 Jun; 154(1-2):225-32. PubMed ID: 16472868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.